APO Research
Talk to an analyst

APO RESEARCH · REPORT

SUS (Single Use System) for Biopharma Process

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global SUS (Single Use System) for Biopharma Process Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchSUS (Single Use System) for Biopharma Process Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal SUS (Single Use System) for Biopharma Process Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal SUS (Single Use System) for Biopharma Process Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SUS (Single Use System) for Biopharma Process Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal SUS (Single Use System) for Biopharma Process Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global SUS (Single Use System) for Biopharma Process market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for SUS (Single Use System) for Biopharma Process is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for SUS (Single Use System) for Biopharma Process is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SUS (Single Use System) for Biopharma Process is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the SUS (Single Use System) for Biopharma Process market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the SUS (Single Use System) for Biopharma Process market include Tofflon, Truking, Duoning Biotechnology, Lepure China, JYSS Bio-Engineering, AUSTAR and Lisure Science, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global SUS (Single Use System) for Biopharma Process market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of SUS (Single Use System) for Biopharma Process and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SUS (Single Use System) for Biopharma Process sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the SUS (Single Use System) for Biopharma Process market size, projected growth trends, production technologies, key applications, and end-use industries.

SUS (Single Use System) for Biopharma Process Segment by Company

Tofflon

Truking

Duoning Biotechnology

Lepure China

JYSS Bio-Engineering

AUSTAR

Lisure Science

SUS (Single Use System) for Biopharma Process Segment by Type

Single Use Bioreactors Bags

Filtration and Sampling Systems

Others

SUS (Single Use System) for Biopharma Process Segment by Application

Cell Therapy

Vaccine Production

MAB and Recombinant Proteins

Others

SUS (Single Use System) for Biopharma Process Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global SUS (Single Use System) for Biopharma Process status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions SUS (Single Use System) for Biopharma Process market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify SUS (Single Use System) for Biopharma Process significant trends, drivers, influence factors in global and regions.

6. To analyze SUS (Single Use System) for Biopharma Process competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SUS (Single Use System) for Biopharma Process market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SUS (Single Use System) for Biopharma Process and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SUS (Single Use System) for Biopharma Process.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the SUS (Single Use System) for Biopharma Process market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global SUS (Single Use System) for Biopharma Process industry.

Chapter 3: Detailed analysis of SUS (Single Use System) for Biopharma Process manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of SUS (Single Use System) for Biopharma Process in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of SUS (Single Use System) for Biopharma Process in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. SUS (Single Use System) for Biopharma Process Industry Trends Table 2. SUS (Single Use System) for Biopharma Process Industry Drivers Table 3. SUS (Single Use System) for Biopharma Process Industry Opportunities and Challenges Table 4. SUS (Single Use System) for Biopharma Process Industry Restraints Table 5. Global SUS (Single Use System) for Biopharma Process Revenue by Company (US$ Million) & (2021-2026) Table 6. Global SUS (Single Use System) for Biopharma Process Revenue Share by Company (2021-2026) Table 7. Global SUS (Single Use System) for Biopharma Process Sales Volume by Company (Units) & (2021-2026) Table 8. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Company (2021-2026) Table 9. Global SUS (Single Use System) for Biopharma Process Average Price (US$/Unit) of Company (2021-2026) Table 10. Global SUS (Single Use System) for Biopharma Process Company Ranking, (2024-2026) & (USD Million) Table 11. Global SUS (Single Use System) for Biopharma Process Key Company Manufacturing Base & Headquarters Table 12. Global SUS (Single Use System) for Biopharma Process Company, Product Type & Application Table 13. Global SUS (Single Use System) for Biopharma Process Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global SUS (Single Use System) for Biopharma Process by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Use Bioreactors Bags Table 18. Significant Companies of Filtration and Sampling Systems Table 19. Significant Companies of Others Table 20. Global SUS (Single Use System) for Biopharma Process Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global SUS (Single Use System) for Biopharma Process Sales Volume by Type (2021-2026) & (Units) Table 22. Global SUS (Single Use System) for Biopharma Process Sales Volume by Type (2027-2032) & (Units) Table 23. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Type (2021-2026) Table 24. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Type (2027-2032) Table 25. Global SUS (Single Use System) for Biopharma Process Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global SUS (Single Use System) for Biopharma Process Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global SUS (Single Use System) for Biopharma Process Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Type (2021-2026) Table 29. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cell Therapy Table 31. Significant Companies of Vaccine Production Table 32. Significant Companies of MAB and Recombinant Proteins Table 33. Significant Companies of Others Table 34. Global SUS (Single Use System) for Biopharma Process Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global SUS (Single Use System) for Biopharma Process Sales Volume by Application (2021-2026) & (Units) Table 36. Global SUS (Single Use System) for Biopharma Process Sales Volume by Application (2027-2032) & (Units) Table 37. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Application (2021-2026) Table 38. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Application (2027-2032) Table 39. Global SUS (Single Use System) for Biopharma Process Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global SUS (Single Use System) for Biopharma Process Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global SUS (Single Use System) for Biopharma Process Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Application (2021-2026) Table 43. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Application (2027-2032) Table 44. Global SUS (Single Use System) for Biopharma Process Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global SUS (Single Use System) for Biopharma Process Sales by Region (2021-2026) & (Units) Table 46. Global SUS (Single Use System) for Biopharma Process Sales Market Share by Region (2021-2026) Table 47. Global SUS (Single Use System) for Biopharma Process Sales by Region (2027-2032) & (Units) Table 48. Global SUS (Single Use System) for Biopharma Process Sales Market Share by Region (2027-2032) Table 49. Global SUS (Single Use System) for Biopharma Process Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global SUS (Single Use System) for Biopharma Process Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Region (2021-2026) Table 52. Global SUS (Single Use System) for Biopharma Process Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Region (2027-2032) Table 54. Global SUS (Single Use System) for Biopharma Process Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global SUS (Single Use System) for Biopharma Process Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global SUS (Single Use System) for Biopharma Process Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global SUS (Single Use System) for Biopharma Process Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global SUS (Single Use System) for Biopharma Process Sales by Country (2021-2026) & (Units) Table 59. Global SUS (Single Use System) for Biopharma Process Sales Market Share by Country (2021-2026) Table 60. Global SUS (Single Use System) for Biopharma Process Sales by Country (2027-2032) & (Units) Table 61. Global SUS (Single Use System) for Biopharma Process Sales Market Share by Country (2027-2032) Table 62. Global SUS (Single Use System) for Biopharma Process Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global SUS (Single Use System) for Biopharma Process Sales Value Market Share by Country (2021-2026) Table 64. Global SUS (Single Use System) for Biopharma Process Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global SUS (Single Use System) for Biopharma Process Sales Value Market Share by Country (2027-2032) Table 66. Tofflon Company Information Table 67. Tofflon Business Overview Table 68. Tofflon SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Tofflon SUS (Single Use System) for Biopharma Process Product Portfolio Table 70. Tofflon Recent Development Table 71. Truking Company Information Table 72. Truking Business Overview Table 73. Truking SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Truking SUS (Single Use System) for Biopharma Process Product Portfolio Table 75. Truking Recent Development Table 76. Duoning Biotechnology Company Information Table 77. Duoning Biotechnology Business Overview Table 78. Duoning Biotechnology SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Duoning Biotechnology SUS (Single Use System) for Biopharma Process Product Portfolio Table 80. Duoning Biotechnology Recent Development Table 81. Lepure China Company Information Table 82. Lepure China Business Overview Table 83. Lepure China SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lepure China SUS (Single Use System) for Biopharma Process Product Portfolio Table 85. Lepure China Recent Development Table 86. JYSS Bio-Engineering Company Information Table 87. JYSS Bio-Engineering Business Overview Table 88. JYSS Bio-Engineering SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. JYSS Bio-Engineering SUS (Single Use System) for Biopharma Process Product Portfolio Table 90. JYSS Bio-Engineering Recent Development Table 91. AUSTAR Company Information Table 92. AUSTAR Business Overview Table 93. AUSTAR SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AUSTAR SUS (Single Use System) for Biopharma Process Product Portfolio Table 95. AUSTAR Recent Development Table 96. Lisure Science Company Information Table 97. Lisure Science Business Overview Table 98. Lisure Science SUS (Single Use System) for Biopharma Process Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Lisure Science SUS (Single Use System) for Biopharma Process Product Portfolio Table 100. Lisure Science Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. SUS (Single Use System) for Biopharma Process Distributors List Table 104. SUS (Single Use System) for Biopharma Process Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. SUS (Single Use System) for Biopharma Process Product Image Figure 2. Global SUS (Single Use System) for Biopharma Process Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 4. Global SUS (Single Use System) for Biopharma Process Sales (2021-2032) & (Units) Figure 5. Global SUS (Single Use System) for Biopharma Process Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global SUS (Single Use System) for Biopharma Process Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Use Bioreactors Bags Image Figure 10. Filtration and Sampling Systems Image Figure 11. Others Image Figure 12. Global SUS (Single Use System) for Biopharma Process Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global SUS (Single Use System) for Biopharma Process Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Type (2021-2032) Figure 15. Global SUS (Single Use System) for Biopharma Process Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global SUS (Single Use System) for Biopharma Process Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Type (2021-2032) Figure 18. Cell Therapy Image Figure 19. Vaccine Production Image Figure 20. MAB and Recombinant Proteins Image Figure 21. Others Image Figure 22. Global SUS (Single Use System) for Biopharma Process Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global SUS (Single Use System) for Biopharma Process Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Application (2021-2032) Figure 25. Global SUS (Single Use System) for Biopharma Process Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global SUS (Single Use System) for Biopharma Process Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Application (2021-2032) Figure 28. Global SUS (Single Use System) for Biopharma Process Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global SUS (Single Use System) for Biopharma Process Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global SUS (Single Use System) for Biopharma Process Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global SUS (Single Use System) for Biopharma Process Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 33. North America SUS (Single Use System) for Biopharma Process Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 35. Europe SUS (Single Use System) for Biopharma Process Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific SUS (Single Use System) for Biopharma Process Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 39. South America SUS (Single Use System) for Biopharma Process Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa SUS (Single Use System) for Biopharma Process Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa SUS (Single Use System) for Biopharma Process Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. SUS (Single Use System) for Biopharma Process Value Chain Figure 127. Manufacturing Cost Structure Figure 128. SUS (Single Use System) for Biopharma Process Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Single Use Bioreactors Bags
  • Filtration and Sampling Systems
  • Others
Applications
  • Cell Therapy
  • Vaccine Production
  • MAB and Recombinant Proteins
  • Others
Companies covered
  • Tofflon
  • Truking
  • Duoning Biotechnology
  • Lepure China
  • JYSS Bio-Engineering
  • AUSTAR
  • Lisure Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  4. 1.2.2 Global SUS (Single Use System) for Biopharma Process Sales Volume (2021-2032)
  5. 1.2.3 Global SUS (Single Use System) for Biopharma Process Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 SUS (Single Use System) for Biopharma Process Market Dynamics
  1. 2.1 SUS (Single Use System) for Biopharma Process Industry Trends
  2. 2.2 SUS (Single Use System) for Biopharma Process Industry Drivers
  3. 2.3 SUS (Single Use System) for Biopharma Process Industry Opportunities and Challenges
  4. 2.4 SUS (Single Use System) for Biopharma Process Industry Restraints
3 SUS (Single Use System) for Biopharma Process Market by Company
  1. 3.1 Global SUS (Single Use System) for Biopharma Process Company Revenue Ranking in 2025
  2. 3.2 Global SUS (Single Use System) for Biopharma Process Revenue by Company (2021-2026)
  3. 3.3 Global SUS (Single Use System) for Biopharma Process Sales Volume by Company (2021-2026)
  4. 3.4 Global SUS (Single Use System) for Biopharma Process Average Price by Company (2021-2026)
  5. 3.5 Global SUS (Single Use System) for Biopharma Process Company Ranking (2024-2026)
  6. 3.6 Global SUS (Single Use System) for Biopharma Process Company Manufacturing Base and Headquarters
  7. 3.7 Global SUS (Single Use System) for Biopharma Process Company Product Type and Application
  8. 3.8 Global SUS (Single Use System) for Biopharma Process Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global SUS (Single Use System) for Biopharma Process Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 SUS (Single Use System) for Biopharma Process Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 SUS (Single Use System) for Biopharma Process Market by Type
  1. 4.1 SUS (Single Use System) for Biopharma Process Type Introduction
  2. 4.1.1 Single Use Bioreactors Bags
  3. 4.1.2 Filtration and Sampling Systems
  4. 4.1.3 Others
  5. 4.2 Global SUS (Single Use System) for Biopharma Process Sales Volume by Type
  6. 4.2.1 Global SUS (Single Use System) for Biopharma Process Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global SUS (Single Use System) for Biopharma Process Sales Volume by Type (2021-2032)
  8. 4.2.3 Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Type (2021-2032)
  9. 4.3 Global SUS (Single Use System) for Biopharma Process Sales Value by Type
  10. 4.3.1 Global SUS (Single Use System) for Biopharma Process Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global SUS (Single Use System) for Biopharma Process Sales Value by Type (2021-2032)
  12. 4.3.3 Global SUS (Single Use System) for Biopharma Process Sales Value Share by Type (2021-2032)
5 SUS (Single Use System) for Biopharma Process Market by Application
  1. 5.1 SUS (Single Use System) for Biopharma Process Application Introduction
  2. 5.1.1 Cell Therapy
  3. 5.1.2 Vaccine Production
  4. 5.1.3 MAB and Recombinant Proteins
  5. 5.1.4 Others
  6. 5.2 Global SUS (Single Use System) for Biopharma Process Sales Volume by Application
  7. 5.2.1 Global SUS (Single Use System) for Biopharma Process Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global SUS (Single Use System) for Biopharma Process Sales Volume by Application (2021-2032)
  9. 5.2.3 Global SUS (Single Use System) for Biopharma Process Sales Volume Share by Application (2021-2032)
  10. 5.3 Global SUS (Single Use System) for Biopharma Process Sales Value by Application
  11. 5.3.1 Global SUS (Single Use System) for Biopharma Process Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global SUS (Single Use System) for Biopharma Process Sales Value by Application (2021-2032)
  13. 5.3.3 Global SUS (Single Use System) for Biopharma Process Sales Value Share by Application (2021-2032)
6 SUS (Single Use System) for Biopharma Process Regional Sales and Value Analysis
  1. 6.1 Global SUS (Single Use System) for Biopharma Process Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global SUS (Single Use System) for Biopharma Process Sales by Region (2021-2032)
  3. 6.2.1 Global SUS (Single Use System) for Biopharma Process Sales by Region: 2021-2026
  4. 6.2.2 Global SUS (Single Use System) for Biopharma Process Sales by Region (2027-2032)
  5. 6.3 Global SUS (Single Use System) for Biopharma Process Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global SUS (Single Use System) for Biopharma Process Sales Value by Region (2021-2032)
  7. 6.4.1 Global SUS (Single Use System) for Biopharma Process Sales Value by Region: 2021-2026
  8. 6.4.2 Global SUS (Single Use System) for Biopharma Process Sales Value by Region (2027-2032)
  9. 6.5 Global SUS (Single Use System) for Biopharma Process Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  12. 6.6.2 North America SUS (Single Use System) for Biopharma Process Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  15. 6.7.2 Europe SUS (Single Use System) for Biopharma Process Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific SUS (Single Use System) for Biopharma Process Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  21. 6.9.2 South America SUS (Single Use System) for Biopharma Process Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa SUS (Single Use System) for Biopharma Process Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa SUS (Single Use System) for Biopharma Process Sales Value Share by Country, 2025 VS 2032
7 SUS (Single Use System) for Biopharma Process Country-level Sales and Value Analysis
  1. 7.1 Global SUS (Single Use System) for Biopharma Process Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global SUS (Single Use System) for Biopharma Process Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global SUS (Single Use System) for Biopharma Process Sales by Country (2021-2032)
  4. 7.3.1 Global SUS (Single Use System) for Biopharma Process Sales by Country (2021-2026)
  5. 7.3.2 Global SUS (Single Use System) for Biopharma Process Sales by Country (2027-2032)
  6. 7.4 Global SUS (Single Use System) for Biopharma Process Sales Value by Country (2021-2032)
  7. 7.4.1 Global SUS (Single Use System) for Biopharma Process Sales Value by Country (2021-2026)
  8. 7.4.2 Global SUS (Single Use System) for Biopharma Process Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt SUS (Single Use System) for Biopharma Process Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt SUS (Single Use System) for Biopharma Process Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt SUS (Single Use System) for Biopharma Process Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tofflon
  2. 8.1.1 Tofflon Company Information
  3. 8.1.2 Tofflon Business Overview
  4. 8.1.3 Tofflon SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tofflon SUS (Single Use System) for Biopharma Process Product Portfolio
  6. 8.1.5 Tofflon Recent Developments
  7. 8.2 Truking
  8. 8.2.1 Truking Company Information
  9. 8.2.2 Truking Business Overview
  10. 8.2.3 Truking SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Truking SUS (Single Use System) for Biopharma Process Product Portfolio
  12. 8.2.5 Truking Recent Developments
  13. 8.3 Duoning Biotechnology
  14. 8.3.1 Duoning Biotechnology Company Information
  15. 8.3.2 Duoning Biotechnology Business Overview
  16. 8.3.3 Duoning Biotechnology SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Duoning Biotechnology SUS (Single Use System) for Biopharma Process Product Portfolio
  18. 8.3.5 Duoning Biotechnology Recent Developments
  19. 8.4 Lepure China
  20. 8.4.1 Lepure China Company Information
  21. 8.4.2 Lepure China Business Overview
  22. 8.4.3 Lepure China SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lepure China SUS (Single Use System) for Biopharma Process Product Portfolio
  24. 8.4.5 Lepure China Recent Developments
  25. 8.5 JYSS Bio-Engineering
  26. 8.5.1 JYSS Bio-Engineering Company Information
  27. 8.5.2 JYSS Bio-Engineering Business Overview
  28. 8.5.3 JYSS Bio-Engineering SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JYSS Bio-Engineering SUS (Single Use System) for Biopharma Process Product Portfolio
  30. 8.5.5 JYSS Bio-Engineering Recent Developments
  31. 8.6 AUSTAR
  32. 8.6.1 AUSTAR Company Information
  33. 8.6.2 AUSTAR Business Overview
  34. 8.6.3 AUSTAR SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AUSTAR SUS (Single Use System) for Biopharma Process Product Portfolio
  36. 8.6.5 AUSTAR Recent Developments
  37. 8.7 Lisure Science
  38. 8.7.1 Lisure Science Company Information
  39. 8.7.2 Lisure Science Business Overview
  40. 8.7.3 Lisure Science SUS (Single Use System) for Biopharma Process Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lisure Science SUS (Single Use System) for Biopharma Process Product Portfolio
  42. 8.7.5 Lisure Science Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 SUS (Single Use System) for Biopharma Process Value Chain Analysis
  2. 9.1.1 SUS (Single Use System) for Biopharma Process Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 SUS (Single Use System) for Biopharma Process Sales Mode & Process
  6. 9.2 SUS (Single Use System) for Biopharma Process Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 SUS (Single Use System) for Biopharma Process Distributors
  9. 9.2.3 SUS (Single Use System) for Biopharma Process Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst